LONDON, June 29 (Reuters) - British drugmaker Indivior
said on Monday it had appointed Mark Crossley as chief
executive to replace Shaun Thaxter, who had stepped down in
mutual agreement with the board.
Crossley has been chief financial officer of the group,
which makes medicines to treat addiction, since 2017, Indivior
said, and as chief strategy officer from 2014-2017 helped lead
the demerger of the company from Reckitt Benckiser.
(Reporting by Paul Sandle; editing by Kate Holton)
